Listed life sciences firm celebrates rise in sales
York-based listed life sciences company Optibiotix has reported total sales worth £808,000 with other income of £617,000 for the year ended 30 November 2019.
The business, which develops compounds to tackle obesity, cardiovascular disease and diabetes, has released an unaudited preliminary revenue figures and a trading, commercial, and strategic update.
It noted that agreements signed in 2019 extended its geographic reach into 24 new countries and contributed to an increase in year on year sales across every division.
Tot... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
